Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valter Gattei

Showing results (1-10 of 190) with videos related to

Pageof 19
Sort By:
Minerva Medica|December 2, 2020
Hepatitis C virus-associated non-Hodgkin lymphomas: the endless historyGabriele Pozzato, Cesare Mazzaro, Valter Gattei
Clinics in Liver Disease|July 11, 2017
Hepatitis C Virus-Associated Non-Hodgkin Lymphomas: Biology, Epidemiology, and TreatmentGabriele Pozzato, Cesare Mazzaro, Valter Gattei
Le Infezioni in Medicina|January 1, 2015
Recombinant Human Erythropoietin (RHuEpo) and Granular Colony Stimulating Factor (G-CSF) in hepatitis C virus (HCV) related to mixed cryoglobulinaemia associated to membranoproliferative glomerulonephritis type I: a case report descriptionEndri Mauro, Valter Gattei, Cesare Mazzaro
Hematological Oncology|July 2, 2009
How would I manage a sample submitted for flow cytometry analysis for suspicious chronic lymphocytic leukaemiaPietro Bulian, Giovanni Del Poeta, Valter Gattei
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2021
<i>TP53</i> Disruption in Chronic Lymphocytic Leukemia Under Ibrutinib: More is Worse?Riccardo Bomben, Antonella Zucchetto, Massimo Gentile, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2023
BCR/Integrin Interaction in CLL: A Physiologic Remnant with Clinical RelevanceErika Tissino, Riccardo Bomben, Valter Gattei, et al.
Frontiers in Bioscience (Landmark Edition)|January 2, 2013
TLR9 signaling defines distinct prognostic subsets in CLLDimitar G Efremov, Riccardo Bomben, Stefania Gobessi, et al.
International Journal of Molecular Sciences|March 27, 2020
VLA-4 Expression and Activation in B Cell Malignancies: Functional and Clinical AspectsAndrea Härzschel, Antonella Zucchetto, Valter Gattei, et al.
Oncotarget|August 26, 2015
The MYC/miR-17-92 axis in lymphoproliferative disorders: A common pathway with therapeutic potentialMichele Dal Bo, Riccardo Bomben, Luis Hernández, et al.
Molecular Immunology|July 12, 2008
APE/Ref-1 makes fine-tuning of CD40-induced B cell proliferationSonia Merluzzi, Giorgia Gri, Valter Gattei, et al.
Pageof 19

Showing results (1-10 of 190) with videos related to

Sort By:
Pageof 19
Minerva Medica|December 2, 2020
Hepatitis C virus-associated non-Hodgkin lymphomas: the endless historyGabriele Pozzato, Cesare Mazzaro, Valter Gattei
Clinics in Liver Disease|July 11, 2017
Hepatitis C Virus-Associated Non-Hodgkin Lymphomas: Biology, Epidemiology, and TreatmentGabriele Pozzato, Cesare Mazzaro, Valter Gattei
Le Infezioni in Medicina|January 1, 2015
Recombinant Human Erythropoietin (RHuEpo) and Granular Colony Stimulating Factor (G-CSF) in hepatitis C virus (HCV) related to mixed cryoglobulinaemia associated to membranoproliferative glomerulonephritis type I: a case report descriptionEndri Mauro, Valter Gattei, Cesare Mazzaro
Hematological Oncology|July 2, 2009
How would I manage a sample submitted for flow cytometry analysis for suspicious chronic lymphocytic leukaemiaPietro Bulian, Giovanni Del Poeta, Valter Gattei
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2021
<i>TP53</i> Disruption in Chronic Lymphocytic Leukemia Under Ibrutinib: More is Worse?Riccardo Bomben, Antonella Zucchetto, Massimo Gentile, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2023
BCR/Integrin Interaction in CLL: A Physiologic Remnant with Clinical RelevanceErika Tissino, Riccardo Bomben, Valter Gattei, et al.
Frontiers in Bioscience (Landmark Edition)|January 2, 2013
TLR9 signaling defines distinct prognostic subsets in CLLDimitar G Efremov, Riccardo Bomben, Stefania Gobessi, et al.
International Journal of Molecular Sciences|March 27, 2020
VLA-4 Expression and Activation in B Cell Malignancies: Functional and Clinical AspectsAndrea Härzschel, Antonella Zucchetto, Valter Gattei, et al.
Oncotarget|August 26, 2015
The MYC/miR-17-92 axis in lymphoproliferative disorders: A common pathway with therapeutic potentialMichele Dal Bo, Riccardo Bomben, Luis Hernández, et al.
Molecular Immunology|July 12, 2008
APE/Ref-1 makes fine-tuning of CD40-induced B cell proliferationSonia Merluzzi, Giorgia Gri, Valter Gattei, et al.
Pageof 19